Menu
Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy » Volume 4
Original Research
The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,504 | Dovepress* | 13,504+ | 1,356 | 14,860 | |
| Totals | 13,504 | 1,356 | 14,860 | ||
|
*Since 23 July 2014 +Since July 2016 |
|||||
View citations on Google Scholar